| Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis AT Shaw, BY Yeap, BJ Solomon, GJ Riely, J Gainor, JA Engelman, ... The lancet oncology 12 (11), 1004-1012, 2011 | 1135 | 2011 |
| Correlation of IHC and FISH for ALK gene rearrangement in non-small cell lung carcinoma: IHC score algorithm for FISH SY Eunhee, JM Boland, JJ Maleszewski, AC Roden, AM Oliveira, ... Journal of Thoracic Oncology 6 (3), 459-465, 2011 | 323 | 2011 |
| Nerve growth factor production by lymphocytes. L Santambrogio, M Benedetti, MV Chao, R Muzaffar, K Kulig, N Gabellini, ... Journal of immunology (Baltimore, Md.: 1950) 153 (10), 4488-4495, 1994 | 254 | 1994 |
| Worse disease-free survival in never-smokers with ALK+ lung adenocarcinoma P Yang, K Kulig, JM Boland, MR Erickson-Johnson, AM Oliveira, ... Journal of Thoracic Oncology 7 (1), 90-97, 2012 | 161 | 2012 |
| Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients HS Park, JK Lee, DW Kim, K Kulig, TM Kim, SH Lee, YK Jeon, DH Chung, ... Lung cancer 77 (2), 288-292, 2012 | 144 | 2012 |
| Sexual activity and substance use among adolescents by category of physical activity plus team sports participation K Kulig, ND Brener, T McManus Archives of pediatrics & adolescent medicine 157 (9), 905-912, 2003 | 141 | 2003 |
| PD-L1 expression by two complementary diagnostic assays and mRNA in situ hybridization in small cell lung cancer H Yu, C Batenchuk, A Badzio, TA Boyle, P Czapiewski, DC Chan, X Lu, ... Journal of Thoracic Oncology 12 (1), 110-120, 2017 | 109 | 2017 |
| Impact of crizotinib on survival in patients with advanced, ALK-positive NSCLC compared with historical controls. AT Shaw, BY Yeap, BJ Solomon, GJ Riely, AJ Iafrate, G Shapiro, ... Journal of Clinical Oncology 29 (15_suppl), 7507-7507, 2011 | 85 | 2011 |
| Comparative analyses of overall survival in patients with anaplastic lymphoma kinase‐positive and matched wild‐type advanced nonsmall cell lung cancer JK Lee, HS Park, DW Kim, K Kulig, TM Kim, SH Lee, YK Jeon, DH Chung, ... Cancer 118 (14), 3579-3586, 2012 | 75 | 2012 |
| Physical and functional association of the major histocompatibility complex class I heavy chain α3 domain with the transporter associated with antigen processing K Kulig, D Nandi, I Bacik, JJ Monaco, S Vukmanovic The Journal of experimental medicine 187 (6), 865-874, 1998 | 60 | 1998 |
| Detection of Anaplastic Lymphoma Kinase (ALK) Gene Rearrangement in Non-Small Cell Lung Cancer and Related Issues in ALK Inhibitor Therapy: A Literature … ES Yi, JH Chung, K Kulig, KM Kerr Molecular diagnosis & therapy 16, 143-150, 2012 | 43 | 2012 |
| Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology images A Sadhwani, HW Chang, A Behrooz, T Brown, I Auvigne-Flament, H Patel, ... Scientific reports 11 (1), 16605, 2021 | 31 | 2021 |
| CD8+ T cell cytolytic activity independent of mitogen‐activated protein kinase / extracellular regulatory kinase signaling (MAP kinase / ERK) M Lilić, K Kulig, I Messaoudi, K Remus, M Janković, J Nikolić‐Žugić, ... European journal of immunology 29 (12), 3971-3977, 1999 | 22 | 1999 |
| A novel wearable device for continuous temperature monitoring & fever detection N Verma, I Haji-Abolhassani, S Ganesh, J Vera-Aguilera, J Paludo, ... IEEE Journal of Translational Engineering in Health and Medicine 9, 1-7, 2021 | 17 | 2021 |
| Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer LS Schwartzberg, P Cobb, F Senecal, D Henry, K Kulig, MS Walker, ... The Breast 18 (2), 78-83, 2009 | 15 | 2009 |
| Inhibition of activation‐induced changes in the structure of the T cell interleukin‐7 receptor by cyclosporin A and FK506 BMJ Foxwell, J L. Willcocks, DA Taylor‐Fishwick, K Kulig, B Ryffel, ... European journal of immunology 23 (1), 85-89, 1993 | 15 | 1993 |
| Early fever detection by a novel wearable continuous temperature monitor in patients undergoing autologous stem cell transplantation J Vera-Aguilera, I Haji-Abolhassani, K Kulig, R Heitz, J Paludo, ... Blood 134, 3481, 2019 | 10 | 2019 |
| Racial, Ethnic, and Geographic Disparities in Rates of Knee Arthroplasty [4](multiple letters) K Kulig, CO Bingham, LL Steele, J Skinner, JN Weinstein New England Journal of Medicine 350 (3), 305-306, 2004 | 9 | 2004 |
| Predictive and prognostic value of ALK gene rearrangement in Non-Small Cell Lung Cancer. K Kulig, WY Wang Yi, S Iyer, YP Yang Ping | 8 | 2014 |
| Abstract A42: ALK and cMET expression in glioblastoma multiforme: Implications for therapeutic targeting. L Hudson, K Kulig, D Young, R McLendon, A Abernethy Molecular Cancer Therapeutics 10 (11_Supplement), A42-A42, 2011 | 8 | 2011 |
